Inovio Pharmaceuticals, Inc.
Q3 2024 13F Holders
Symbol
INO
CUSIP
45773H409
Type
Equity
Class
COM SHS
Num filings
107
Total reported value, excl. options
$49.5 M
Compare 2024 Q3 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type